Gleber-Netto Frederico O, Braakhuis Boudewijn J M, Triantafyllou Asterios, Takes Robert P, Kelner Natalie, Rodrigo Juan P, Strojan Primož, Vander Poorten Vincent, Rapidis Alexander D, Rinaldo Alessandra, Brakenhoff Ruud H, Ferlito Alfio, Kowalski Luiz P
Laboratory of Medical Genomics, International Research Center, A. C. Camargo Cancer Center, São Paulo, Brazil.
Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.
Oral Oncol. 2015 Aug;51(8):738-44. doi: 10.1016/j.oraloncology.2015.04.016. Epub 2015 May 16.
Relapses have a great impact on both the morbidity and mortality rates of oral squamous cell carcinoma (OSCC) patients. Current classification criteria are imprecise and need improvements. Recent advances in understanding of OSCC relapses on a molecular level provide new possibilities to better classify true recurrences and second primary tumors. This review discusses the limitations of the current OSCC relapse classification method and presents possible alternatives to improve this classification based on molecular techniques. Moreover, these molecular techniques add to the further understanding of these lesions and may provide tools for clinical management.
复发对口腔鳞状细胞癌(OSCC)患者的发病率和死亡率都有很大影响。目前的分类标准不精确,需要改进。最近在分子水平上对OSCC复发的认识进展为更好地分类真正的复发和第二原发性肿瘤提供了新的可能性。本文综述讨论了当前OSCC复发分类方法的局限性,并提出了基于分子技术改进该分类的可能替代方法。此外,这些分子技术有助于进一步了解这些病变,并可能为临床管理提供工具。